Table 2 Initial clinical parameters according to the M-CHARTS-detected metamorphopsia in patients with resolved central serous chorioretinopathy
With metamorphopsia (n = 19) | Without metamorphopsia (n = 17) | P value | |
|---|---|---|---|
BCVA (logMAR) | 0.3 ± 0.3 | 0.2 ± 0.2 | 0.383 |
Height of subretinal fluid (μm) | 190.6 ± 151.7 | 220.8 ± 153.0 | 0.447 |
Pigment epithelial detachment (n, %) | 4, 21.1 % | 6, 35.3 % | 0.341 |
RPE irregularities (n, %) | 11, 57.9 % | 4, 23.5 % | 0.037 |
External limiting membrane | 0.25 | ||
Intact (n, %) | 6, 31.6 % | 9, 52.9 % | |
Focal disruption (n, %) | 5, 26.3 % | 5, 29.4 % | |
Broad disruption (n, %) | 8, 42.1 % | 3, 17.6 % | |
Photoreceptor IS/OS junction | 0.342 | ||
Intact (n, %) | 0, 0 % | 0, 0 % | |
Focal disruption (n, %) | 6, 31.6 % | 8, 47.1 % | |
Broad disruption (n, %) | 13, 68.4 % | 9, 52.9 % | |
COST line | 0.09 | ||
Intact (n, %) | 0, 0 % | 0, 0 % | |
Focal disruption (n, %) | 3, 15.8 % | 7, 41.2 % | |
Broad disruption (n, %) | 16, 84.2 % | 10, 58.8 % |